These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 23811386)
21. In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase. Musilova L; Kuca K; Jung YS; Jun D Clin Toxicol (Phila); 2009 Jul; 47(6):545-50. PubMed ID: 19586353 [TBL] [Abstract][Full Text] [Related]
22. Optimization of Cholinesterase-Based Catalytic Bioscavengers Against Organophosphorus Agents. Lushchekina SV; Schopfer LM; Grigorenko BL; Nemukhin AV; Varfolomeev SD; Lockridge O; Masson P Front Pharmacol; 2018; 9():211. PubMed ID: 29593539 [TBL] [Abstract][Full Text] [Related]
23. Effectiveness of a substituted β-cyclodextrin to prevent cyclosarin toxicity in vivo. Worek F; Seeger T; Zengerle M; Kubik S; Thiermann H; Wille T Toxicol Lett; 2014 Apr; 226(2):222-7. PubMed ID: 24561299 [TBL] [Abstract][Full Text] [Related]
24. Catalytic bioscavengers as countermeasures against organophosphate nerve agents. Goldsmith M; Ashani Y Chem Biol Interact; 2018 Aug; 292():50-64. PubMed ID: 29990481 [TBL] [Abstract][Full Text] [Related]
25. The potential role of bioscavenger in the medical management of nerve-agent poisoned casualties. Rice H; Mann TM; Armstrong SJ; Price ME; Green AC; Tattersall JEH Chem Biol Interact; 2016 Nov; 259(Pt B):175-181. PubMed ID: 27144491 [TBL] [Abstract][Full Text] [Related]
26. A comprehensive evaluation of novel oximes in creation of butyrylcholinesterase-based nerve agent bioscavengers. Katalinić M; Maček Hrvat N; Baumann K; Morasi Piperčić S; Makarić S; Tomić S; Jović O; Hrenar T; Miličević A; Jelić D; Žunec S; Primožič I; Kovarik Z Toxicol Appl Pharmacol; 2016 Nov; 310():195-204. PubMed ID: 27654152 [TBL] [Abstract][Full Text] [Related]
27. Pseudo-catalytic scavenging: searching for a suitable reactivator of phosphorylated butyrylcholinesterase. Kovarik Z; Katalinić M; Sinko G; Binder J; Holas O; Jung YS; Musilova L; Jun D; Kuca K Chem Biol Interact; 2010 Sep; 187(1-3):167-71. PubMed ID: 20206154 [TBL] [Abstract][Full Text] [Related]
28. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase. Bartling A; Worek F; Szinicz L; Thiermann H Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809 [TBL] [Abstract][Full Text] [Related]
29. Human plasma-derived BuChE as a stoichiometric bioscavenger for treatment of nerve agent poisoning. Mumford H; Docx CJ; Price ME; Green AC; Tattersall JE; Armstrong SJ Chem Biol Interact; 2013 Mar; 203(1):160-6. PubMed ID: 22981459 [TBL] [Abstract][Full Text] [Related]
30. Characterization of Cholinesterases From Multiple Large Animal Species for Medical Countermeasure Development Against Chemical Warfare Nerve Agents. McGarry KG; Schill KE; Winters TP; Lemmon EE; Sabourin CL; Harvilchuck JA; Moyer RA Toxicol Sci; 2020 Mar; 174(1):124-132. PubMed ID: 31879781 [TBL] [Abstract][Full Text] [Related]
31. Counteracting poisoning with chemical warfare nerve agents. Hrvat NM; Kovarik Z Arh Hig Rada Toksikol; 2020 Dec; 71(4):266-284. PubMed ID: 33410774 [TBL] [Abstract][Full Text] [Related]
32. Targeting organophosphorus compounds poisoning by novel quinuclidine-3 oximes: development of butyrylcholinesterase-based bioscavengers. Zandona A; Katalinić M; Šinko G; Radman Kastelic A; Primožič I; Kovarik Z Arch Toxicol; 2020 Sep; 94(9):3157-3171. PubMed ID: 32583098 [TBL] [Abstract][Full Text] [Related]
33. Engineered Recombinant PON1-OPH Fusion Hybrids: Potentially Effective Catalytic Bioscavengers against Organophosphorus Nerve Agent Analogs. Lee N; Yun H; Lee C; Lee Y; Kim E; Kim S; Jeon H; Yu C; Rho J J Microbiol Biotechnol; 2021 Jan; 31(1):144-153. PubMed ID: 33144547 [TBL] [Abstract][Full Text] [Related]
34. In vitro characterization of organophosphorus compound hydrolysis by native and recombinant human prolidase. Chandrasekaran L; Belinskaya T; Saxena A Toxicol In Vitro; 2013 Feb; 27(1):499-506. PubMed ID: 22677456 [TBL] [Abstract][Full Text] [Related]
35. Catalytic bioscavengers in nerve agent poisoning: A promising approach? Worek F; Thiermann H; Wille T Toxicol Lett; 2016 Feb; 244():143-148. PubMed ID: 26200600 [TBL] [Abstract][Full Text] [Related]
36. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry. Li H; Schopfer LM; Nachon F; Froment MT; Masson P; Lockridge O Toxicol Sci; 2007 Nov; 100(1):136-45. PubMed ID: 17698511 [TBL] [Abstract][Full Text] [Related]
37. Mechanisms of organophosphate toxicity and detoxication with emphasis on studies in Croatia. Reiner E; Radić Z; Simeon-Rudolf V Arh Hig Rada Toksikol; 2007 Sep; 58(3):329-38. PubMed ID: 17913688 [TBL] [Abstract][Full Text] [Related]
38. Nonquaternary reactivators for organophosphate-inhibited cholinesterases. Kalisiak J; Ralph EC; Cashman JR J Med Chem; 2012 Jan; 55(1):465-74. PubMed ID: 22206546 [TBL] [Abstract][Full Text] [Related]
39. [Organophosphorus poisoning: Towards enzymatic treatments]. Jacquet P; Poirier L; Daudé D; Chabrière E Ann Pharm Fr; 2019 Sep; 77(5):349-362. PubMed ID: 31253354 [TBL] [Abstract][Full Text] [Related]
40. An in vitro and in vivo evaluation of the efficacy of recombinant human liver prolidase as a catalytic bioscavenger of chemical warfare nerve agents. Rezk PE; Zdenka P; Sabnekar P; Kajih T; Mata DG; Wrobel C; Cerasoli DM; Chilukuri N Drug Chem Toxicol; 2015 Jan; 38(1):37-43. PubMed ID: 24641262 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]